Dipeptidyl peptidase
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 8: | Line 8: | ||
* '''DPP-II''' is a serine protease.<br /> | * '''DPP-II''' is a serine protease.<br /> | ||
* '''DPP-III''' acts similarly to DPP-IV.<br /> | * '''DPP-III''' acts similarly to DPP-IV.<br /> | ||
- | * '''DPP-IV''' (or '''CD26''') cleaves proline dipeptides from the N-termini and is associated with immune regulation. For details see: [[Dipeptidyl peptidase IV]] | + | * '''DPP-IV''' (or '''CD26''') cleaves proline dipeptides from the N-termini and is associated with immune regulation. |
+ | For details see: | ||
+ | *[[Dipeptidyl peptidase IV]] | ||
+ | *[[Saxagliptin]] | ||
+ | *[[Sitagliptin]] | ||
+ | *[[Vildagliptin]] | ||
+ | *[[Treatments:Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics]] | ||
+ | *[[Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics]]. | ||
+ | |||
* '''DPP-XI''' from ''Porphyromonas gingivalis'' cleaves preferentially substrates with Asp/Glu at the P1 position<ref>PMID:26057589</ref>.<br /> | * '''DPP-XI''' from ''Porphyromonas gingivalis'' cleaves preferentially substrates with Asp/Glu at the P1 position<ref>PMID:26057589</ref>.<br /> | ||
Line 27: | Line 35: | ||
</StructureSection> | </StructureSection> | ||
- | == 3D Structures of Dipeptidyl peptidase == | ||
- | |||
- | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
- | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | |||
- | *DPP-I see [[Cathepsin]] C. | ||
- | |||
- | *DPP-II | ||
- | |||
- | **[[3n0t]] – hDPP-II peptidase domain residues 28-492+inhibitor<br /> | ||
- | **[[3jyh]], [[4ebb]] – hDPP-II peptidase domain residues 28-492<br /> | ||
- | |||
- | *DPP-III | ||
- | |||
- | **[[3fvy]], [[5egy]] – hDPP-III<br /> | ||
- | **[[3t6b]], [[3t6j]] - hDPP-III (mutant) + tynorphin<br /> | ||
- | **[[5e2q]] - hDPP-III (mutant) + angiotensin II<br /> | ||
- | **[[5e33]], [[5e3a]] - hDPP-III (mutant) + enkephalin <br /> | ||
- | **[[5e3c]] - hDPP-III (mutant) + opioid peptide<br /> | ||
- | **[[5ehh]] - hDPP-III (mutant) + endomorphin II<br /> | ||
- | **[[3csk]] – DPP-III (mutant) – yeast<br /> | ||
- | **[[5yfb]], [[5yfc]], [[5yfd]] – DPP-III – mushroom<br /> | ||
- | |||
- | *DPP-IV (CD26) | ||
- | |||
- | **[[2onc]], [[1tk3]], [[1r9m]], [[1j2e]], [[1nu6]], [[1pfq]] – hDPP-IV extracellular domain<br /> | ||
- | **[[1u8e]] – hDPP-IV extracellular domain (mutant)<br /> | ||
- | **[[3kwj]], [[3oc0]], [[3kwf]], [[3q8w]] – hDPP-IV extracellular domain +quinoline derivative<br /> | ||
- | **[[3g0b]], [[3g0d]], [[3g0g]], [[3nox]], [[3hab]], [[3hac]], [[3f8s]], [[3h0c]], [[3ccb]], [[3ccc]], [[2qjr]], [[2qky]], [[3d4l]], [[2jid]], [[3bjm]], [[2rip]], [[2ole]], [[2rgu]], [[2i78]], [[2oag]], [[2oqv]], [[2oqi]], [[2ogz]], [[2i03]], [[2g5p]], [[2g5t]], [[2g63]], [[2bub]], [[2ajl]], [[1wcy]], [[1rwq]], [[1tkr]], [[1n1m]], [[3eio]], [[3g0c]], [[3opm]], [[3sww]], [[3sx4]], [[3q0t]], [[4a5s]], [[3vjk]], [[3vjl]], [[3vjm]], [[3w2t]], [[4dsa]], [[4dsz]], [[4dtc]], [[4g1f]],[[3o95]], [[3o9v]], [[4j3j]], [[4jh0]], [[4lko]], [[4n8d]], [[4n8e]], [[4pnz]], [[4pv7]], [[3wqh]], [[5i7u]], [[5j3j]], [[5kby]], [[5t4b]], [[5t4e]], [[5t4f]], [[5t4h]], [[5zid]], [[5y7k]], [[5y7j]], [[5y7h]] – hDPP-IV extracellular domain+inhibitor<br /> | ||
- | **[[6b1e]], [[6b1o]] – hDPP-IV extracellular domain (mutant) +inhibitor<br /> | ||
- | **[[1r9n]], [[2bgr]], [[1nu8]] – hDPP-IV extracellular domain+polypeptide<br /> | ||
- | **[[1w1i]] – hDPP-IV extracellular domain+adenosine deaminase<br /> | ||
- | **[[2bgn]] – hDPP-IV extracellular domain+adenosine deaminase+polypeptide<br /> | ||
- | **[[3c43]], [[3c45]], [[2qoe]], [[2qt9]], [[2qtb]], [[2p8s]], [[2oph]], [[2fjp]], [[1x70]], [[2iit]], [[2iiv]], [[3qbj]], [[5ism]] – hDPP-IV extracellular domain (mutant) + inhibitor <br /> | ||
- | **[[4kr0]], [[4qzv]] - hDPP-IV extracellular domain + S protein<br /> | ||
- | **[[4l72]] – rDPP-IV + Mers-Cov Rbd<br /> | ||
- | **[[2gbc]] – rDPP-IV extracellular domain<br /> | ||
- | **[[2oae]], [[2i3z]], [[2gbf]], [[2gbg]], [[2gbi]] – rDPP-IV extracellular domain+inhibitor<br /> | ||
- | **[[4ffv]], [[4ffw]], [[5vta]] – rDPP-IV + antibody<br /> | ||
- | **[[2aj8]], [[2ajb]], [[2ajc]], [[2ajd]], [[2bua]], [[2buc]], [[1orw]], [[5lls]] – pDPP-IV extracellular domain+inhibitor - pig<br /> | ||
- | **[[1orv]] - pDPP-IV extracellular domain<br /> | ||
- | **[[2ecf]] - DPP-IV – ''Stenotrophomonas maltophilia''<br /> | ||
- | **[[5olj]] – PgDPP-IV – ''Porphyromonas gingivalis''<br /> | ||
- | |||
- | *DPP-VI | ||
- | |||
- | **[[3pvq]], [[4r0k]] – DPP-VI – ''Bacterioides thetaiotamicron'' | ||
- | |||
- | *DPP-VIII | ||
- | |||
- | **[[6eos]], [[6eoo]] – hDPP-VIII <br /> | ||
- | **[[6eot]], [[6eop]] – hDPP-VIII + polypeptide<br /> | ||
- | |||
- | *DPP-IX | ||
- | |||
- | **[[6eoq]], [[6eor]] – hDPP-IX <br /> | ||
- | |||
- | *DPP-X | ||
- | |||
- | **[[4wjl]] – hDPP-X extracellular domain<br /> | ||
- | |||
- | *DPP-XI or peptidase S46 or Asp/Glu-specific DPP | ||
- | |||
- | **[[4xzy]], [[4y01]], [[4y02]], [[4y04]] – PgDPP-XI <br /> | ||
- | **[[5jxp]], [[5jxk]], [[5jwf]] – PeDPP-XI – ''Porphyromonas endodontalis''<br /> | ||
- | **[[5jy0]], [[5jxf]], [[5jwi]], [[5jwg]] – PeDPP-XI + polypeptide <br /> | ||
- | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
|
References
- ↑ Sakamoto Y, Suzuki Y, Iizuka I, Tateoka C, Roppongi S, Fujimoto M, Inaka K, Tanaka H, Yamada M, Ohta K, Gouda H, Nonaka T, Ogasawara W, Tanaka N. Structural and mutational analyses of dipeptidyl peptidase 11 from Porphyromonas gingivalis reveal the molecular basis for strict substrate specificity. Sci Rep. 2015 Jun 9;5:11151. doi: 10.1038/srep11151. PMID:26057589 doi:http://dx.doi.org/10.1038/srep11151
- ↑ Pro B, Dang NH. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol. 2004 Oct;19(4):1345-51. PMID:15375776
- ↑ Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract. 2006 Nov;60(11):1454-70. PMID:17073841 doi:10.1111/j.1742-1241.2006.01178.x
- ↑ Itou M, Kawaguchi T, Taniguchi E, Sata M. Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol. 2013 Apr 21;19(15):2298-306. doi:, 10.3748/wjg.v19.i15.2298. PMID:23613622 doi:http://dx.doi.org/10.3748/wjg.v19.i15.2298
- ↑ Furber M, Tiden AK, Gardiner P, Mete A, Ford R, Millichip I, Stein L, Mather A, Kinchin E, Luckhurst C, Barber S, Cage P, Sanganee H, Austin R, Chohan K, Beri R, Thong B, Wallace A, Oreffo V, Hutchinson R, Harper S, Debreczeni J, Breed J, Wissler L, Edman K. Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate. J Med Chem. 2014 Mar 14. PMID:24592859 doi:http://dx.doi.org/10.1021/jm401705g